PETS PETMED EXPRESS INC
Retail-Drug Stores and Proprietary Stores · Nasdaq · SEC CIK 1040130 · Fiscal year ends 03/31
Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-17.4%
TTM net income YoY50.6%
TTM EPS YoY51.1%
Revenue 3-yr CAGR-15.2%
Net income 3-yr CAGR—
Margins
Gross margin27.8%
Operating margin-18.0%
Net margin-17.0%
FCF margin-15.4%
EBITDA margin-12.3%
Returns
ROE-90.8%
ROA-34.1%
ROIC (approx.)-366.8%
Asset turnover2.01x
Leverage & solvency
Liabilities / assets71.6%
Debt / equity0.00x
Current ratio0.60x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.83x
Accruals ratio-5.6%
Payout ratio—
Capex / revenue1.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2027Q22026-09-30 | 2027Q12026-06-30 | 2026Q4*2026-03-31 | 2026Q32025-12-31 | 2026Q22025-09-30 | 2026Q12025-06-30 | 2025Q4*2025-03-31 | 2025Q32024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $35.77M | $41.02M | $42.82M | $40.66M | $44.36M | $51.18M | $46.47M | $51.96M |
| Cost of revenue | $25.97M | $29.68M | — | — | $31.95M | $36.78M | $27.52M | $35.83M |
| Gross profit | $9.80M | $11.33M | $13.94M | $9.46M | $12.41M | $14.40M | $18.95M | $16.13M |
| SG&A expense | $11.97M | $11.20M | $11.41M | $12.19M | $14.18M | $12.95M | $12.49M | $10.79M |
| Operating income | -$6.42M | -$6.23M | -$5.69M | -$10.47M | -$8.38M | -$34.13M | -$6.02M | -$450,000 |
| Interest expense | $200,000 | $400,000 | — | $400,000 | $600,000 | $500,000 | — | $400,000 |
| Pretax income | -$6.42M | -$6.13M | -$4.16M | -$10.54M | -$8.51M | -$34.14M | -$5.98M | -$242,000 |
| Income tax | $14,000 | $13,000 | -$102,000 | $11,000 | $9,000 | $9,000 | $5.66M | $465,000 |
| Net income | -$6.43M | -$6.14M | -$4.06M | -$10.55M | -$8.52M | -$34.15M | -$11.64M | -$707,000 |
| EBITDA | -$4.24M | -$4.08M | -$3.27M | -$8.07M | -$6.10M | -$31.85M | -$3.95M | $1.14M |
| EPS (basic) | -0.31 | -0.28 | — | -0.50 | -0.41 | -1.65 | — | -0.03 |
| EPS (diluted) | -0.31 | -0.28 | — | -0.50 | -0.41 | -1.65 | — | -0.03 |
| Dividends declared per share | — | — | — | — | — | — | 0.00 | 0.00 |
| Weighted avg. shares (diluted) | 21.07M | 21.68M | — | 21.01M | 20.89M | 20.76M | — | 20.63M |
| Balance sheet | ||||||||
| Cash & equivalents | $11.42M | $13.08M | $21.41M | $26.91M | $36.10M | $41.13M | $54.72M | $50.10M |
| Receivables | $1.37M | $1.71M | $1.91M | $1.56M | $1.97M | $1.60M | $2.32M | $2.26M |
| Inventory | $6.30M | $8.47M | $13.61M | $12.21M | $14.77M | $18.36M | $16.20M | $11.79M |
| Current assets | $25.34M | $27.61M | $43.56M | $48.51M | $59.45M | $67.89M | $78.87M | $68.38M |
| PP&E, net | $23.47M | $25.21M | $26.33M | $27.55M | $28.34M | $28.84M | $28.86M | $28.43M |
| Goodwill | — | — | $0 | $0 | $0 | $0 | $26.66M | $26.66M |
| Intangibles | $5.01M | $5.25M | $5.49M | $5.98M | $6.47M | $6.96M | $8.05M | $9.73M |
| Total assets | $59.40M | $63.76M | $81.19M | $87.97M | $100.30M | $109.84M | $148.70M | $144.79M |
| Current liabilities | $42.37M | $40.60M | $52.03M | $54.77M | $56.68M | $57.62M | $62.77M | $47.96M |
| Total liabilities | $42.54M | $40.77M | $52.25M | $55.20M | $57.24M | $58.29M | $63.57M | $48.61M |
| Shareholders' equity | $16.86M | $22.99M | $28.94M | $32.77M | $43.06M | $51.55M | $85.13M | $96.18M |
| Shares outstanding | 22.13M | 21.68M | 21.39M | 21.38M | 21.02M | 20.84M | 20.66M | 20.66M |
| Cash flow statement | ||||||||
| Operating cash flow | -$1.06M | -$7.69M | -$4.74M | -$9.21M | -$2.17M | -$12.27M | $7.01M | -$1.17M |
| Capital expenditure | $586,000 | $641,000 | $720,000 | -$21,000 | $2.62M | $1.29M | $2.39M | $777,000 |
| Free cash flow | -$1.64M | -$8.33M | -$5.46M | -$9.18M | -$4.80M | -$13.56M | $4.62M | -$1.94M |
| Investing cash flow | -$586,000 | -$641,000 | -$720,000 | $21,000 | -$2.62M | -$1.29M | -$2.39M | -$777,000 |
| Financing cash flow | -$18,000 | -$5,000 | -$38,000 | $0 | -$231,000 | -$30,000 | -$5,000 | -$1,000 |
| Depreciation & amortization | $2.18M | $2.15M | $2.43M | $2.40M | $2.28M | $2.28M | $2.07M | $1.59M |
| Stock-based compensation | $326,000 | $198,000 | $272,000 | $300,000 | $200,000 | $591,000 | $593,000 | $500,000 |
| Dividends paid | $0 | $0 | -$3,000 | $1,000 | $22,000 | $1,000 | $5,000 | $1,000 |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.